Browsing byAuthorAmariles, P
Showing results 1 to 7 of 7
| Issue Date | Title | Author(s) |
| 2010-10-01 | Clinical value of blood pressure measurement in the community pharmacy | Sabater-Hernández, D; Azpilicueta, I; Sánchez-Villegas, P; Amariles, P; Baena, MI; Faus, MJ |
| 2008-01 | Efecto del Metodo Dader de Seguimiento Farmacoterapéutico en el riesgo cardiovascular de pacientes con factores de riesgo o enfermedad cardiovascular (EMDADER-CV): Metodos y resultados globales | Amariles, P; Faus, MJ; Jimenez- Martin, J; Sabater Hernandez, D; Garcia-Jimenez, E |
| 2012-01-01 | Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial | Amariles, P; Sabater-Hernández, D; García-Jiménez, E; Rodríguez-Chamorro, MA; Prats-Más, R; Marín-Magán, F; Galán-Ceballos, JA; Jiménez-Martín, J; José Faus, M |
| 2015-10-01 | Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes | Ocampo, CC; Garcia-Cardenas, V; Martinez-Martinez, F; Benrimoj, SI; Amariles, P; Gastelurrutia, MA |
| 2011-08-01 | Magnitude of the white-coat effect in the community pharmacy setting: The MEPAFAR study | Sabater-Hernández, D; De La Sierra, A; Sánchez-Villegas, P; Baena, MI; Amariles, P; Faus, MJ |
| 2011-06-01 | Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study | Sabater-Hernández, D; Sánchez-Villegas, P; García-Corpas, JP; Amariles, P; Sendra-Lillo, J; Faus, MJ |
| 2016-11-01 | Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies | Amariles, P; Pino-Marín, D; Sabater-Hernández, D; García-Jiménez, E; Roig-Sánchez, I; Faus, MJ |
